Pacira biosciences, inc. (PCRX)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Dec'10
ASSETS
Current assets:
Cash and cash equivalents

54,589

78,228

85,139

59,737

215,036

132,526

230,941

116,871

41,563

54,126

26,216

53,814

108,970

35,944

24,442

25,309

35,029

56,984

30,522

32,722

40,897

37,520

17,756

108,200

18,762

12,515

3,383

8,626

26,272

10,126

8,709

21,445

25,213

46,168

16,402

27,450

26,133

Restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

1,509

1,829

2,168

0

1,633

1,975

998

-

1,523

1,791

1,847

-

1,299

1,687

2,069

1,314

Short-term investments

263,875

213,722

180,505

232,502

197,406

250,928

155,468

254,450

298,225

257,221

267,864

328,628

274,729

136,653

136,686

137,358

114,992

101,981

115,916

120,425

113,989

119,138

131,972

55,660

45,811

59,637

78,464

87,330

83,974

30,924

58,240

62,840

29,617

29,985

20,666

19,755

-

Accounts receivable, net

38,988

47,530

42,573

41,147

39,766

38,000

34,266

35,641

31,203

31,658

27,021

27,467

27,702

29,937

26,765

28,651

25,901

25,855

25,919

24,281

24,511

22,366

20,517

20,545

15,969

14,590

9,771

7,756

5,243

4,352

2,459

3,214

860

2,113

1,496

1,055

1,191

Inventories, net

59,666

58,296

60,238

52,697

47,028

48,569

44,884

42,053

40,043

41,411

39,112

33,602

30,311

31,278

37,476

60,916

63,744

61,645

56,132

48,769

36,264

29,263

23,662

19,194

15,364

15,557

15,606

14,221

10,760

12,077

11,906

9,299

5,078

1,245

1,667

1,884

1,605

Prepaid expenses and other current assets

14,476

10,781

10,392

8,526

9,437

7,946

6,490

6,039

7,700

6,694

5,622

7,480

6,252

9,277

10,075

5,755

8,959

6,117

4,611

3,429

4,089

4,461

3,504

3,139

2,572

2,819

2,486

2,559

2,740

1,920

2,024

1,431

1,496

1,839

1,482

1,391

812

Total current assets

431,594

408,557

378,847

394,609

508,673

477,969

472,049

455,054

418,734

391,110

365,835

450,991

447,964

243,089

235,444

257,989

248,625

252,582

233,100

229,626

219,750

214,257

199,240

208,906

98,478

106,751

111,685

121,490

128,989

60,922

85,129

100,076

62,264

82,649

43,400

53,604

31,055

Long-term investments

35,120

64,798

70,577

25,362

0

25,871

0

1,601

21,683

60,047

80,807

-

-

0

0

0

13,470

13,462

17,921

17,941

19,938

24,431

24,527

13,474

-

0

-

-

-

-

-

-

-

-

-

-

-

Fixed assets, net

108,105

104,681

104,856

105,492

107,051

108,670

110,063

111,276

109,225

107,046

105,947

103,239

102,571

101,016

100,388

99,282

95,846

90,324

86,323

77,809

67,206

60,632

56,148

53,513

49,891

48,182

45,944

42,065

41,130

39,116

35,319

29,966

26,492

25,103

25,825

24,633

23,950

Right-of-use assets, net

37,613

38,124

35,756

36,494

26,686

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Goodwill

99,500

99,500

99,547

100,538

62,000

62,040

62,040

59,912

57,490

55,197

52,956

50,943

48,829

46,737

44,670

42,751

32,784

30,880

28,888

27,123

25,381

23,761

22,048

12,520

11,327

10,328

9,539

8,980

8,582

8,297

8,109

7,992

-

-

-

-

-

Intangibles, net

102,421

104,387

106,354

108,320

-

0

-

-

-

-

-

-

-

-

0

0

0

81

161

242

323

403

483

564

644

1,157

1,670

2,183

2,695

3,208

3,721

4,233

4,746

5,259

7,204

7,780

8,912

Equity investment and other assets

6,979

10,971

11,552

17,028

14,146

14,803

14,146

14,146

14,146

14,146

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other assets

-

-

-

-

560

-

747

692

759

825

545

572

598

624

651

677

481

406

2,595

2,252

2,432

2,588

2,948

3,103

3,353

3,402

3,557

3,712

3,845

511

548

586

762

479

1,180

1,075

2,645

Total assets

821,379

831,065

807,489

787,843

719,156

689,353

659,045

642,681

622,037

628,371

606,090

605,745

599,962

391,466

381,153

400,699

391,206

387,735

368,988

354,993

335,030

326,072

305,394

292,080

163,693

169,820

172,395

178,430

185,241

112,054

132,826

142,853

94,264

113,490

77,609

87,092

66,562

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable

15,850

12,799

16,064

13,347

13,369

14,368

13,795

14,260

14,913

14,658

12,278

10,392

9,373

7,511

7,287

4,614

10,484

8,739

8,471

13,299

5,565

6,758

7,747

3,145

2,605

3,069

1,559

1,712

1,001

2,569

4,789

440

2,302

3,440

4,313

5,052

4,315

Accrued expenses

44,717

70,427

61,002

51,907

39,696

45,865

40,359

38,434

33,017

41,057

39,701

46,755

34,900

36,666

31,077

38,330

29,067

35,375

30,295

26,790

25,296

28,311

23,383

23,035

16,913

17,885

15,573

12,260

9,872

9,792

13,036

9,279

7,040

7,159

4,998

3,641

4,983

Lease liabilities

3,968

4,935

5,043

6,172

5,583

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Convertible senior notes

-

-

0

0

0

338

334

330

327

324

320

319

759

0

107,563

106,388

105,215

104,040

104,907

103,885

104,135

103,100

102,065

101,031

99,996

98,961

97,927

-

-

0

-

-

-

-

-

-

-

Contingent consideration

14,041

18,179

13,591

11,500

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current portion of royalty interest obligation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

276

602

869

1,065

1,020

941

891

853

823

837

1,164

1,221

1,219

1,293

1,459

1,575

Current portion of deferred revenue

-

-

-

-

-

-

-

-

-

102

-

-

520

595

822

1,048

1,275

1,426

1,426

1,426

1,426

1,426

1,426

1,426

1,008

1,008

972

972

972

972

1,166

4,353

7,231

13,054

2,354

2,458

2,267

Income taxes payable

1,737

1,333

138

78

343

90

35

0

111

76

38

44

96

66

82

58

98

208

312

72

31

139

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current portion of long-term debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,364

7,039

4,871

4,869

3,182

Total current liabilities

80,313

107,673

95,838

83,004

58,991

60,661

54,523

53,024

48,368

56,217

52,337

57,510

45,648

44,838

146,831

150,438

146,139

149,788

145,411

145,472

136,453

140,010

135,223

129,506

121,587

121,943

116,972

15,835

12,698

14,156

19,828

15,236

19,158

31,911

17,829

17,479

16,322

Convertible senior notes

310,078

306,045

302,081

298,185

294,356

290,592

286,893

283,258

279,685

276,173

272,721

269,328

265,992

108,738

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Lease liabilities

40,189

40,938

38,882

39,041

29,297

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contingent consideration

15,227

19,963

22,206

16,970

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Related party debt, including accrued interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

49,795

Long-term debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

96,892

95,857

25,191

24,930

24,670

23,632

18,537

20,603

20,358

21,869

Royalty interest obligation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

226

403

584

723

857

881

1,270

1,442

1,537

1,842

2,220

2,996

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

7,357

-

7,617

7,747

7,877

8,082

8,439

8,795

9,152

9,508

9,864

10,221

2,960

3,212

2,991

3,234

3,477

3,720

4,343

4,634

8,073

8,416

17,847

18,414

18,138

Contingent purchase liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,042

2,042

2,042

2,042

2,042

Deferred rent

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,352

-

Other liabilities

1,535

1,502

2,320

8,993

8,993

16,874

16,363

15,886

15,463

16,498

16,232

17,859

10,332

18,914

12,557

14,163

11,020

11,473

6,125

5,447

5,404

5,409

5,235

4,384

3,435

3,190

2,911

2,743

2,694

2,275

2,399

2,538

2,675

2,778

3,571

2,292

3,783

Total liabilities

447,342

476,121

461,327

446,193

391,637

368,127

357,779

352,168

343,516

348,888

341,290

344,697

329,329

172,490

167,005

172,348

165,036

169,343

159,975

159,714

151,009

154,927

150,322

144,111

127,982

128,571

123,277

119,288

115,449

46,199

52,381

48,348

57,022

65,221

63,734

64,157

114,945

Commitments and contingencies (Note 16)

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

-

-

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Stockholders’ equity:
Preferred stock, par value $0.001; 5,000,000 shares authorized; none issued and outstanding at March 31, 2020 and December 31, 2019

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

6

Common stock, par value $0.001; 250,000,000 shares authorized; 42,116,545 shares issued and outstanding at March 31, 2020; 41,908,148 shares issued and outstanding at December 31, 2019

42

42

42

42

41

41

41

41

41

41

41

40

40

37

37

37

37

37

37

37

36

36

36

36

34

34

34

33

33

33

32

32

25

25

17

17

1

Additional paid-in capital

766,280

753,978

740,183

729,531

718,449

709,691

697,977

686,888

677,836

669,032

658,557

647,206

637,066

565,207

556,405

548,277

538,227

526,696

514,796

504,146

492,898

481,334

470,975

460,907

343,578

337,639

333,542

328,787

325,375

298,317

296,525

294,806

229,335

228,470

178,821

178,368

88,523

Accumulated deficit

-391,239

-399,398

-394,510

-388,423

-391,153

-388,226

-396,511

-395,871

-398,455

-389,136

-393,731

-386,134

-366,391

-346,238

-342,266

-320,101

-312,143

-308,289

-305,791

-308,877

-308,885

-310,145

-315,947

-312,943

-307,906

-296,429

-284,473

-269,689

-255,658

-232,520

-216,174

-200,429

-192,133

-180,239

-164,956

-155,448

-136,911

Accumulated other comprehensive income (loss)

-1,046

322

447

500

182

-280

-241

-545

-901

-454

-67

-64

-82

-30

-28

138

49

-52

-29

-27

-28

-80

8

-31

5

5

17

13

44

27

64

98

17

15

-5

-

-

Treasury stock at cost, none at December 31, 2013 and 1,065 shares at December 31, 2012

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2

2

2

2

2

2

2

2

2

2

2

Total stockholders’ equity

374,037

354,944

346,162

341,650

327,519

321,226

301,266

290,513

278,521

279,483

264,800

261,048

270,633

218,976

214,148

228,351

226,170

218,392

209,013

195,279

184,021

171,145

155,072

147,969

35,711

41,249

49,118

59,142

69,792

65,855

80,445

94,505

37,242

48,269

13,875

22,935

-48,383

Total liabilities and stockholders’ equity

821,379

831,065

807,489

787,843

719,156

689,353

659,045

642,681

622,037

628,371

606,090

605,745

599,962

391,466

381,153

400,699

391,206

387,735

368,988

354,993

335,030

326,072

305,394

292,080

163,693

169,820

172,395

178,430

185,241

112,054

132,826

142,853

94,264

113,490

77,609

87,092

66,562

Preferred stock, par value (in dollars per share)

0.00

0.00

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Preferred stock, shares authorized

5,000

5,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Preferred stock, shares issued

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Preferred stock, shares outstanding

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Common stock, par value (in dollars per share)

0.00

0.00

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Common stock, shares authorized

250,000

250,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Common stock, shares outstanding

42,116

41,908

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-